LIVE FROM SEC EDGAR
Every SEC filing that moves stocks, the minute it lands.
Earnings, insider buys and sells, 5% stakes, IPO filings and red flags, summarized in plain English.
8-KInsider
5% stakeIPORed flag
center = newest
Filings per hour last 24 hours
bioAffinity Technologies, Inc.BIAF · Nov 6, 5:28 PM ET
bioAffinity reports Q3 2026 net loss of $5.3 million; CyPath Lung unit sales doubled
bioAffinity Technologies reported third-quarter 2026 revenue of approximately $1.1 million and a net loss of approximately $5.3 million, while CyPath Lung test unit sales rose 100% through Q3 versus the first nine months of 2025.
AI-generated summary, checked against the filing. Can contain errors: read the original filing ↗. Not investment advice.